Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them

Details for Australian Patent Application No. 2004213356 (hide)

Owner AstraZeneca AB

Inventors Pimm, Austen; Caffrey, Moya; Ford, Rhonan

Agent Freehills

Pub. Number AU-B-2004213356

PCT Pub. Number WO2004/074224

Priority 0300480-1 21.02.03 SE

Filing date 19 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 15 March 2007

International Classifications

C07C 237/30 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/074224 Priority application(s): WO2004/074224

15 March 2007 Application Accepted

  Published as AU-B-2004213356

12 July 2007 Standard Patent Sealed

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213363-Toggle-action closure

2004213342-Identity card and travel document